CSCRX | VSGAX | CSCRX / VSGAX | |
Total Expense Ratio | 0.90 | 0.07 | 1,286% |
Annual Report Gross Expense Ratio | 0.90 | 0.07 | 1,286% |
Fund Existence | 13 years | 14 years | - |
Gain YTD | 18.282 | 7.865 | 232% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.74B | 38.6B | 7% |
Annual Yield % from dividends | 0.00 | 0.56 | - |
Returns for 1 year | 25.12 | 14.36 | 175% |
Returns for 3 years | 79.83 | 45.45 | 176% |
Returns for 5 years | 23.59 | 40.07 | 59% |
Returns for 10 years | 27.34 | 154.50 | 18% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LABU | 103.28 | 2.83 | +2.82% |
Direxion Daily S&P Biotech Bull 3X ETF | |||
XPH | 49.00 | 0.73 | +1.51% |
SPDR® S&P Pharmaceuticals ETF | |||
GLDM | 76.92 | 0.60 | +0.79% |
SPDR® Gold MiniShares | |||
VXZ | 55.52 | -0.13 | -0.24% |
iPath® B S&P 500® VIX Md-Trm Futs™ ETN | |||
NVDG | 20.24 | -0.28 | -1.36% |
Leverage Shares 2X Long Nvda Daily ETF |